Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6085)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2017 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ozono Y, Nagata K, Hasuike S, Iwakiri H, Nakamura K, Tsuchimochi M, Yamada Y, Takaishi Y, Sueta M, Miike T, Tahara Y, Yamamoto S, Shide K, Hidaka T, Kubuki Y, Kusumoto K, Ochiai T, Kato J, Komada N, Hirono S, Kuroki K, Shigehira M, Shimoda K. Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1. World J Hepatol 2017; 9(36): 1340-1345 [PMID: 29359017 DOI: 10.4254/wjh.v9.i36.1340] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i36/1340.htm |
| Number | Citing Articles |
| 1 |
Tung Huynh, Ke-Qin Hu. Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data. Digestive Diseases and Sciences 2021; 66(4): 1327 doi: 10.1007/s10620-020-06286-3
|
| 2 |
Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong‐Ju Yoo. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(7): 496 doi: 10.1111/jvh.13679
|
| 3 |
Antonio Riccardo Buonomo, Riccardo Scotto, Carmine Coppola, Biagio Pinchera, Giulio Viceconte, Costanza Maria Rapillo, Laura Staiano, Mariarosaria Saturnino, Ferdinando Scarano, Federica Portunato, Mariantonietta Pisaturo, Stefania De Pascalis, Salvatore Martini, Grazia Tosone, Salvatore Nappa, Nicola Coppola, Ivan Gentile. Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence. Medicine 2020; 99(6): e18948 doi: 10.1097/MD.0000000000018948
|
| 4 |
Hiroki Kaneko, Yoshinori Ozono, Hisayoshi Iwakiri, Hiroshi Hatada, Naomi Uchiyama, Yuri Komaki, Kenichi Nakamura, Satoru Hasuike, Kenji Nagata, Hiroshi Kawakami. Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. Clinical Journal of Gastroenterology 2024; doi: 10.1007/s12328-024-01944-9
|
| 5 |
Patricia Amoros-Reboredo, Dolors Soy, Marta Hernandez-Hernandez, Sabela Lens, Conxita Mestres. Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health 2020; 17(11): 3776 doi: 10.3390/ijerph17113776
|
| 6 |
Yuka Aimono, Noriko Kohyama, Toshiro Kamoshida, Toshinori Yamamoto, Mari Kogo. Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy. European Journal of Hospital Pharmacy 2021; 28(e1): e29 doi: 10.1136/ejhpharm-2020-002215
|
| 7 |
Patricia Amoros-Reboredo, Josep Miquel Sotoca, Zoe Mariño, Sergio Rodríguez-Tajes, Anna Pocurull, Dolors Soy, Xavier Forns, Sabela Lens. Efficacy and safety of direct-acting antivirals in older patients with cirrhosis and high comorbidity index. European Journal of Gastroenterology & Hepatology 2020; 32(3): 389 doi: 10.1097/MEG.0000000000001518
|
| 8 |
Masashi Mizokami, Lauren J. Liu, Naoto Fujiyama, Marcus Littman, Jason Yuan, Tomoko Sekiya, Charlotte Hedskog, Leslie J. Ng. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 2021; 28(1): 129 doi: 10.1111/jvh.13395
|